Latest drug development News | Page 2

Tabletop particle accelerator could transform medicine and materials science
Researchers unveil potential new treatment for Motor Neurone Disease
UWA Research Recognised In Innovator Of Year Awards
Revealing the molecular structures of sugars using galectin-10 protein crystals
World First: Lab Grown Diamonds To Transform Tech
Scientists uncover key mechanisms that drive an enzyme linked to aging and cancer
Australian scientists awarded $2.5 million CSL Centenary Fellowships to advance lifelong immunity research and AI-designed proteins
Novel Drug Could Fill Treatment Void For Most Severe Heart Attack Patients
Scientists Reveal First High-Resolution Structure of Key Herpes Virus Protein, Opening Path to New Antivirals
Unlocking Structural Analysis Of Alkaloids With New Metal-organic Framework
QIMR Berghofer Science Powers Breakthrough In Cancer Immunotherapy
A new analytical tool to optimize the potency and selectivity of drugs
Martin Bergö: “We owe it to humankind to use this technology”
Fischbach-Teschl to lead Engineering Innovations in Medicine initiative
Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation
If quantum computing is answering unknowable questions, how do we know theyre right?
New Tool Tackles Unreliable Research Trials
Hoping to prepare the way for more precise schizophrenia therapies
AI reveals how protein modifications link mutations to disease
Bioengineered bacteria could lead to therapeutic antibody drugs
World-first clinical trial reveals unprecedented insights into brain cancer treatment
Innovators Improving Sustainability And Health Outcomes
Beanies kickstart new chase for brain cancer treatment options
Neighbours are stronger together: helping save lives in the ASEAN region
Five surprising ways quantum is changing the world in areas you wouldnt expect
Hidden role of ‘cell protector’ opens cancer treatment possibilities
Scientists discover new drug candidates for nerve pain and ischemic disease
Toxic fungus from King Tutankhamun’s tomb yields cancer-fighting compounds – new study
New Potential Drug Targets for Multiple Sclerosis Identified
LabPMM® Receives New York State Approval for the NPM1 MRD Assay – Informing Therapy and Accelerating Targeted Trials
ERC Grant For World-leading Glaucoma Research At KI
Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Northern Gritstone Invests In Manchester Spinout Apini
FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem
How Mini-organs Can Replace Animal Testing
Physics Advance Details New Way to Control Solid Objects in Liquid
Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic…
Smarter, faster AI models explored for molecular, materials discovery
Australian researchers use a quantum computer to simulate how real molecules behave
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
Melbourne scientists identify potential new target for neurodegenerative diseases
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling…
New Cystic Fibrosis Research Centre Sets Up In Melbourne
Cancer research in the US is world class because of its broad base of funding − with the government pulling out, its…
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
A Colloidal Crystal Model for Controlled Polymorph Selection
Scientists develop new method to measure and predict hydrogen bond strength in confined water